AtriCure Inc
F:A5I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AtriCure Inc
F:A5I
|
US |
|
Marimaca Copper Corp
F:E2E
|
CL |
Intrinsic Value
The intrinsic value of
AtriCure Inc (A5I) under the Base Case is 32.56 EUR per share.
Compared with the current market price of 59.5 EUR, the stock appears
Overvalued by 45% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What AtriCure Does
AtriCure makes medical devices used by heart surgeons to treat atrial fibrillation and related heart rhythm problems. Its products include surgical ablation tools that create controlled scar lines in the heart tissue, plus systems used to remove or close off the left atrial appendage, a part of the heart linked to stroke risk in some patients. The company sells mainly to hospitals and cardiac surgery teams.
- Headquarters
- United States of America US
- Employees
- 1 350
- IPO date
- Aug 5, 2005
Revenue & Expenses Breakdown
AtriCure Inc
Earnings Waterfall
AtriCure Inc
The intrinsic value for
AtriCure Inc (A5I) under the Base Case is 32.56 EUR.
Compared with the current market price of 59.5 EUR, the stock appears Overvalued by 45% .